Clindamycin-resistant clone of Clostridium difficile PCR ribotype 027, Europe

Emerging Infectious Diseases

Volumn 14, Issue 9, 2008, Pages 1485-1487

  Drudy, Denise ^a   Goorhuis, Bram ^b   Bakker, Dennis ^b   Kyne, Lorraine ^a   Van Den Berg, Renate ^b   Fenelon, Lynda ^a   Fanning, Seamus ^a   Kuijper, Edward J ^b,c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN;

BACTERIAL INFECTION; BACTERIUM ISOLATE; CLONING; CLOSTRIDIUM DIFFICILE; EUROPE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; UNITED STATES;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; HUMANS; POLYMERASE CHAIN REACTION;

EID: 50849086757     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1409.071346     Document Type: Letter

References (10)

1. Kuijper EJ, Coignard B, Tull P. the ES-CMID Study Group for Clostridium difficile (ESGCD)*; EU Member States and the European Centre for Disease Prevention and Control (ECDC). Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12:2-18. DOI: 10.1111/j.1469-0691.2006.01580.x
2. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-41. DOI: 10.1056/NEJMoa051590
3. van den Berg RJ, Schaap I, Templeton KE, Klaassen CH, Kuijper EJ. Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J Clin Microbiol. 2007;45:1024-8. DOI: 10.1128/JCM.02023-06
4. Marsh JW, O'Leary MM, Shutt KA, Pasculle AW, Johnson S, Gerding DN, et al. Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in hospitals. J Clin Microbiol. 2006;44:2558-66. DOI: 10.1128/JCM.02364-05
5. Fawley WN, Freeman J, Smith C, Harmanus C, van den Berg RJ, Kuijper EJ, et al. Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains. J Clin Microbiol. 2008;46:954-60. DOI: 10.1128/JCM.01764-07
6. Long S, Fenelon L, Fitzgerald S, Nolan N, Burns K, Hannan M, et al. First isolation and report of clusters of Clostridium difficile PCR 027 cases in Ireland. Eurosurveillance 2007;12:E070426.3.
7. Drudy D, Kyne L, O'Mahony R, Fanning S. GyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis. 2007;13:504-5.
8. Goorhuis A, Van der Kooi T, Vaessen N, Dekker FW, Van den Berg R, Harmanus C, et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis. 2007;45:695-703. DOI: 10.1086/520984
9. Bourgault AM, Lamothe F, Loo VG, Poirier L; CDAD-CSI Study Group. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada. Antimicrob Agents Chemother. 2006;50:3473-5. DOI: 10.1128/AAC.00479-06
10. MacCannell DR, Louie TJ, Gregson DB, Laverdiere M, Labbe AC, Laing F, et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol. 2006;44:2147-52. DOI: 10.1128/JCM.02563-05